PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,245,000 | -24.8% | 125,010 | 0.0% | 0.09% | -35.3% |
| Q2 2021 | $1,655,000 | -24.3% | 125,010 | 0.0% | 0.14% | -34.7% |
| Q1 2021 | $2,185,000 | -75.2% | 125,010 | -63.7% | 0.21% | -71.8% |
| Q4 2020 | $8,807,000 | +95.0% | 344,438 | 0.0% | 0.76% | +30.6% |
| Q3 2020 | $4,516,000 | -46.7% | 344,438 | 0.0% | 0.58% | -65.9% |
| Q2 2020 | $8,472,000 | -5.4% | 344,438 | -42.9% | 1.69% | -50.3% |
| Q1 2020 | $8,960,000 | – | 603,338 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |